Skip to content

Clinical trials

Observational Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Observational Clear all

1,495 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200110
20028
20038
200418
200532
200633
200736
200831
200946
201054
201160
201257
201348
201465
201556
201675
201796
201869
201983
202076
202186
202264
202391
202494
202598
202657

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed852
Unknown status303
Recruiting139
Not yet recruiting61
Terminated52
Withdrawn32
Active, not recruiting32
Enrolling by invitation22
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca83
Boehringer Ingelheim81
GlaxoSmithKline40
Assiut University23
Imperial College London22
National Heart, Lung, and Blood Institute (NHLBI)20
Weill Medical College of Cornell University18
Peking University Third Hospital17
Brigham and Women's Hospital14
University Medical Center Groningen14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive1,495
Asthma199
Emphysema92
Heart Failure68
Lung Diseases61
Dyspnea47
Diabetes Mellitus43
Lung Neoplasms42
Bronchitis, Chronic41
Bronchiectasis37

Trials

Showing 1 to 25 of 1,495. Each trial links to its page on Pharma Observatory.

1,395 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.